Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Return on Assets (2017 - 2025)

Vistagen Therapeutics (VTGN) has disclosed Return on Assets for 11 consecutive years, with 0.92% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 43.0% to 0.92% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.92% through Dec 2025, down 43.0% year-over-year, with the annual reading at 0.49% for FY2025, 9.0% down from the prior year.
  • Return on Assets hit 0.92% in Q4 2025 for Vistagen Therapeutics, down from 0.83% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.16% in Q1 2021 to a low of 2.57% in Q2 2023.
  • Historically, Return on Assets has averaged 0.83% across 5 years, with a median of 0.58% in 2025.
  • Biggest five-year swings in Return on Assets: soared 358bps in 2021 and later plummeted -175bps in 2023.
  • Year by year, Return on Assets stood at 0.39% in 2021, then plummeted by -364bps to 1.81% in 2022, then skyrocketed by 80bps to 0.37% in 2023, then plummeted by -31bps to 0.49% in 2024, then plummeted by -89bps to 0.92% in 2025.
  • Business Quant data shows Return on Assets for VTGN at 0.92% in Q4 2025, 0.83% in Q3 2025, and 0.73% in Q2 2025.